ChemoCentryx, Inc.

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 6.92%162.450.0%$2977.41m
BNGOBioNano Genomics, Inc. -5.82%11.500.0%$2371.93m
GILDGilead Sciences, Inc. -1.19%65.911.0%$647.58m
AMGNAmgen, Inc. -1.48%254.781.3%$576.01m
REGNRegeneron Pharmaceuticals, Inc. -4.93%517.302.7%$473.45m
ALXNAlexion Pharmaceuticals, Inc. -2.06%158.422.0%$465.56m
ILMNIllumina, Inc. -0.40%418.883.5%$442.05m
CRSPCRISPR Therapeutics AG -2.51%165.280.6%$434.40m
NVAXNovavax, Inc. 1.87%129.5492.9%$414.73m
VRTXVertex Pharmaceuticals, Inc. -4.32%227.381.9%$363.15m
SRPTSarepta Therapeutics, Inc. -1.64%91.1313.8%$337.78m
BNTXBioNTech SE 3.07%109.550.0%$317.38m
BIIBBiogen, Inc. -2.45%265.011.7%$315.68m
EXASEXACT Sciences Corp. -2.97%136.8519.6%$244.19m
SRNESorrento Therapeutics, Inc. 28.76%13.421.4%$230.95m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.